Our analyses showed that there were significant differences in ANXA2 and ANXA2 pseudogenes expression among the four GBM subtypes in TCGA dataset (P<0.001, P<0.001, P<0.001 and P=0.004, respectively; Figure 2C). This evidence concerns the gene ANXA2 and glioblastoma.